Mark Garland Gustafson's most recent trade in Alzamend Neuro Inc was a trade of 20,000 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on March 31, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alzamend Neuro Inc | Mark Garland Gustafson | Director | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 31 Mar 2022 | 20,000 | 60,000 | - | 1.2 | 24,202 | Common Stock |
| Alzamend Neuro Inc | Mark Garland Gustafson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 50,000 | 0 | - | - | Restricted Stock Grant | |
| Alzamend Neuro Inc | Mark Garland Gustafson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 50,000 | 80,000 | - | 0 | Common Stock |